Dr. Plimack on Immunotherapy Combinations in Bladder Cancer – OncLive
OncLive |
Dr. Plimack on Immunotherapy Combinations in Bladder Cancer
OncLive Elizabeth Plimack, MD, director of Genitourinary Clinical Research at Fox Chase Cancer Center, discusses immunotherapy combinations for patients with bladder cancer. There are trials that are in development investigating checkpoint inhibitors. For … |
